India's hospital sector delivered robust financial performance in Q1FY27, with combined India hospital sales reaching ₹11,740 crore, up 21.3% year-on-year. As reported by CNBC TV18, India hospital EBITDA rose 21.9% to ₹2,701 crore, demonstrating the sector's resilience despite ongoing capacity expansion challenges. The seven hospital chains tracked by Kotak Institutional Equities - Apollo Hospitals, Aster DM Healthcare, KIMS, Max Healthcare, Medanta (Global Health), Narayana Hrudayalaya and Rainbow Children's Medicare - all contributed to this strong growth trajectory. Operational beds across Kotak's coverage increased 15.3% year-on-year during the quarter, while capacity beds rose 15.6%, indicating continued expansion in healthcare infrastructure.
According to CNBC TV18 analysis, Rainbow Children's Medicare leads with the highest EBITDA margin at 28.6%, followed by Max Healthcare at 24.3% and Apollo Hospitals at 24.2%. Narayana Hrudayalaya reported 23.0% EBITDA margin, while Medanta achieved 21.5% and Aster DM Healthcare recorded 20.2%. KIMS showed the lowest margin at 18.9%. However, as noted by CNBC TV18, the distinction between EBITDA and net profit is crucial, as several hospital chains reported EBITDA margins above 20% during the quarter, but their final profit margins are much lower after accounting for depreciation, interest, taxes and other costs. The industry's median profit after tax is around 8%, which operators describe as reasonable for a capital-intensive, bricks-and-mortar business.
Healthcare industry stakeholders have raised serious concerns over a parliamentary committee's recommendation to cap private hospital room rates at the average price of nearby three-star hotels. According to Business Standard, the proposal is part of a report on healthcare affordability and accessibility in India, but industry leaders warn it could make quality healthcare financially unsustainable. Madhu Sasidhar, president and CEO of Apollo Hospitals, stated that the move may impact healthcare expansion in India, noting that India has only 0.7 beds per 1,000 people compared to developed countries with four beds per 1,000 and the WHO average of 2.5. The healthcare industry faces more than 25,000 compliances, most of which are expensive to undertake, while even the hospitality industry doesn't face such regulatory burdens. As Sasidhar emphasized, "Indian private sector hospitals provide quality healthcare at a fraction of the global cost."
The hospital business requires substantial ongoing investment despite strong operational performance. As reported by CNBC TV18, Apollo incurred ₹37.5 crore in pre-operative expenses and losses from new units during Q1FY27, while its established hospitals reported an EBITDA margin of 25.9%. Max Healthcare had ₹195 crore of overheads related to new units, including the Kalinga Hospital acquisition. The cost of adding hospital capacity has risen sharply, with Fortis Healthcare MD & CEO Ashutosh Raghuvanshi noting that the capital cost of adding hospital capacity is currently around ₹2.5-3 crore per bed on average, depending on factors such as land prices, construction and equipment costs. New facilities typically take time to build occupancy and reach maturity, which can weigh on margins in the early stages, creating a significant time lag between capital investment and full earnings realization.
Senior healthcare executives have expressed caution about proposed pricing reforms, arguing they may not address the core affordability challenges. Viren Shetty, Vice Chairman of Narayana Health, stated that capping room charges would not address the main drivers of healthcare costs, noting that patients come to hospitals for treatment, doctors and clinical expertise, while the cost of running a hospital includes medical equipment, clinical infrastructure and infection-control systems. He argued that the focus should shift towards how healthcare is financed, pointing to India's high dependence on out-of-pocket spending and advocating for insurance and employer-funded healthcare to play a bigger role. Max Healthcare Chairman and MD Abhay Soi took a different view, stating that affordability ultimately depends on people's income and purchasing power rather than hospital pricing alone. The industry consensus suggests that while hospital chains are generating strong operating returns, they are also spending heavily on new hospitals and beds, creating a complex equation where profitability depends on both pricing and capacity expansion strategies.
According to Sachin Bajaj, Executive Vice President and Chief Investment Officer at Axis Max Life, Indian equities are showing signs of stabilisation after a sharp correction in the first half of 2026. As reported by ETMarkets, the markets appear to be moving into a more favourable phase with improving fundamentals supporting recent gains. Q1 FY27 earnings growth is expected to exceed 15%, marking a meaningful improvement in the earnings trajectory and bringing an end to the prolonged phase of largely single-digit earnings growth. Corporate commentary has been broadly positive, with companies maintaining a constructive outlook on demand. Bajaj notes that after two consecutive months of gains, the recovery is increasingly being supported by improving fundamentals rather than being purely liquidity-driven. The visibility of growth for FY27 has improved significantly, providing a stronger fundamental backdrop for sustained market performance.
